Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia

D. J. Holt, M. M. Herman, T. M. Hyde, J. E. Kleinman, C. M. Sinton, D. C. German, L. B. Hersh, A. M. Graybiel, C. B. Saper

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Neurochemical and functional abnormalities of the striatum have been reported in schizophrenic brains, but the cellular substrates of these changes are not known. We hypothesized that schizophrenia may involve an abnormality in one of the key modulators of striatal output, the cholinergic interneuron. We measured the densities of cholinergic neurons in the striatum in schizophrenic and control brains in a blind analysis, using as a marker of this cell population immunoreactivity for choline acetyltransferase, the synthetic enzyme of acetylcholine. As an independent marker, we used immunoreactivity for calretinin, a protein which is co-localized with choline acetyltransferase in virtually all of the cholinergic interneurons of the striatum. A significant decrease in choline acetyltransferase-positive and calretinin-positive cell densities was found in the schizophrenic cases compared with controls in the striatum as a whole [for the choline acetyltransferase-positive cells: controls: 3.21 ± 0.48 cells/mm2 (mean ± S.D.), schizophrenics: 2.43 ± 0.68 cells/mm2; P < 0.02]. The decrease was patchy in nature and most prominent in the ventral striatum (for the choline acetyltransferase-positive cells: controls: 3.47 ± 0.59 cells/mm2, schizophrenics: 2.52 ± 0.64 cells/mm2; P < 0.005) which included the ventral caudate nucleus and nucleus accumbens region. Three of the schizophrenic cases with the lowest densities of cholinergic neurons had not been treated with neuroleptics for periods from more than a month to more than 20 years. A decrease in the number or function of the cholinergic interneurons of the striatum may disrupt activity in the ventral striatal-pallidal-thalamic-prefrontal cortex pathway and thereby contribute to abnormalities in function of the prefrontal cortex in schizophrenia.

Original languageEnglish (US)
Pages (from-to)21-31
Number of pages11
JournalNeuroscience
Volume94
Issue number1
DOIs
StatePublished - Sep 1999

Fingerprint

Interneurons
Cholinergic Agents
Choline O-Acetyltransferase
Schizophrenia
Calbindin 2
Corpus Striatum
Cholinergic Neurons
Prefrontal Cortex
Caudate Nucleus
Nucleus Accumbens
Brain
Antipsychotic Agents
Acetylcholine
Cell Count
Enzymes
Population
Proteins

Keywords

  • Basal ganglia
  • Cholinergic
  • Human
  • Interneuron
  • Schizophrenia
  • Striatum

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Holt, D. J., Herman, M. M., Hyde, T. M., Kleinman, J. E., Sinton, C. M., German, D. C., ... Saper, C. B. (1999). Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience, 94(1), 21-31. https://doi.org/10.1016/S0306-4522(99)00279-1

Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. / Holt, D. J.; Herman, M. M.; Hyde, T. M.; Kleinman, J. E.; Sinton, C. M.; German, D. C.; Hersh, L. B.; Graybiel, A. M.; Saper, C. B.

In: Neuroscience, Vol. 94, No. 1, 09.1999, p. 21-31.

Research output: Contribution to journalArticle

Holt, DJ, Herman, MM, Hyde, TM, Kleinman, JE, Sinton, CM, German, DC, Hersh, LB, Graybiel, AM & Saper, CB 1999, 'Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia', Neuroscience, vol. 94, no. 1, pp. 21-31. https://doi.org/10.1016/S0306-4522(99)00279-1
Holt, D. J. ; Herman, M. M. ; Hyde, T. M. ; Kleinman, J. E. ; Sinton, C. M. ; German, D. C. ; Hersh, L. B. ; Graybiel, A. M. ; Saper, C. B. / Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. In: Neuroscience. 1999 ; Vol. 94, No. 1. pp. 21-31.
@article{faa3a6f8cddd4c338271c356eb84b7f3,
title = "Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia",
abstract = "Neurochemical and functional abnormalities of the striatum have been reported in schizophrenic brains, but the cellular substrates of these changes are not known. We hypothesized that schizophrenia may involve an abnormality in one of the key modulators of striatal output, the cholinergic interneuron. We measured the densities of cholinergic neurons in the striatum in schizophrenic and control brains in a blind analysis, using as a marker of this cell population immunoreactivity for choline acetyltransferase, the synthetic enzyme of acetylcholine. As an independent marker, we used immunoreactivity for calretinin, a protein which is co-localized with choline acetyltransferase in virtually all of the cholinergic interneurons of the striatum. A significant decrease in choline acetyltransferase-positive and calretinin-positive cell densities was found in the schizophrenic cases compared with controls in the striatum as a whole [for the choline acetyltransferase-positive cells: controls: 3.21 ± 0.48 cells/mm2 (mean ± S.D.), schizophrenics: 2.43 ± 0.68 cells/mm2; P < 0.02]. The decrease was patchy in nature and most prominent in the ventral striatum (for the choline acetyltransferase-positive cells: controls: 3.47 ± 0.59 cells/mm2, schizophrenics: 2.52 ± 0.64 cells/mm2; P < 0.005) which included the ventral caudate nucleus and nucleus accumbens region. Three of the schizophrenic cases with the lowest densities of cholinergic neurons had not been treated with neuroleptics for periods from more than a month to more than 20 years. A decrease in the number or function of the cholinergic interneurons of the striatum may disrupt activity in the ventral striatal-pallidal-thalamic-prefrontal cortex pathway and thereby contribute to abnormalities in function of the prefrontal cortex in schizophrenia.",
keywords = "Basal ganglia, Cholinergic, Human, Interneuron, Schizophrenia, Striatum",
author = "Holt, {D. J.} and Herman, {M. M.} and Hyde, {T. M.} and Kleinman, {J. E.} and Sinton, {C. M.} and German, {D. C.} and Hersh, {L. B.} and Graybiel, {A. M.} and Saper, {C. B.}",
year = "1999",
month = "9",
doi = "10.1016/S0306-4522(99)00279-1",
language = "English (US)",
volume = "94",
pages = "21--31",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia

AU - Holt, D. J.

AU - Herman, M. M.

AU - Hyde, T. M.

AU - Kleinman, J. E.

AU - Sinton, C. M.

AU - German, D. C.

AU - Hersh, L. B.

AU - Graybiel, A. M.

AU - Saper, C. B.

PY - 1999/9

Y1 - 1999/9

N2 - Neurochemical and functional abnormalities of the striatum have been reported in schizophrenic brains, but the cellular substrates of these changes are not known. We hypothesized that schizophrenia may involve an abnormality in one of the key modulators of striatal output, the cholinergic interneuron. We measured the densities of cholinergic neurons in the striatum in schizophrenic and control brains in a blind analysis, using as a marker of this cell population immunoreactivity for choline acetyltransferase, the synthetic enzyme of acetylcholine. As an independent marker, we used immunoreactivity for calretinin, a protein which is co-localized with choline acetyltransferase in virtually all of the cholinergic interneurons of the striatum. A significant decrease in choline acetyltransferase-positive and calretinin-positive cell densities was found in the schizophrenic cases compared with controls in the striatum as a whole [for the choline acetyltransferase-positive cells: controls: 3.21 ± 0.48 cells/mm2 (mean ± S.D.), schizophrenics: 2.43 ± 0.68 cells/mm2; P < 0.02]. The decrease was patchy in nature and most prominent in the ventral striatum (for the choline acetyltransferase-positive cells: controls: 3.47 ± 0.59 cells/mm2, schizophrenics: 2.52 ± 0.64 cells/mm2; P < 0.005) which included the ventral caudate nucleus and nucleus accumbens region. Three of the schizophrenic cases with the lowest densities of cholinergic neurons had not been treated with neuroleptics for periods from more than a month to more than 20 years. A decrease in the number or function of the cholinergic interneurons of the striatum may disrupt activity in the ventral striatal-pallidal-thalamic-prefrontal cortex pathway and thereby contribute to abnormalities in function of the prefrontal cortex in schizophrenia.

AB - Neurochemical and functional abnormalities of the striatum have been reported in schizophrenic brains, but the cellular substrates of these changes are not known. We hypothesized that schizophrenia may involve an abnormality in one of the key modulators of striatal output, the cholinergic interneuron. We measured the densities of cholinergic neurons in the striatum in schizophrenic and control brains in a blind analysis, using as a marker of this cell population immunoreactivity for choline acetyltransferase, the synthetic enzyme of acetylcholine. As an independent marker, we used immunoreactivity for calretinin, a protein which is co-localized with choline acetyltransferase in virtually all of the cholinergic interneurons of the striatum. A significant decrease in choline acetyltransferase-positive and calretinin-positive cell densities was found in the schizophrenic cases compared with controls in the striatum as a whole [for the choline acetyltransferase-positive cells: controls: 3.21 ± 0.48 cells/mm2 (mean ± S.D.), schizophrenics: 2.43 ± 0.68 cells/mm2; P < 0.02]. The decrease was patchy in nature and most prominent in the ventral striatum (for the choline acetyltransferase-positive cells: controls: 3.47 ± 0.59 cells/mm2, schizophrenics: 2.52 ± 0.64 cells/mm2; P < 0.005) which included the ventral caudate nucleus and nucleus accumbens region. Three of the schizophrenic cases with the lowest densities of cholinergic neurons had not been treated with neuroleptics for periods from more than a month to more than 20 years. A decrease in the number or function of the cholinergic interneurons of the striatum may disrupt activity in the ventral striatal-pallidal-thalamic-prefrontal cortex pathway and thereby contribute to abnormalities in function of the prefrontal cortex in schizophrenia.

KW - Basal ganglia

KW - Cholinergic

KW - Human

KW - Interneuron

KW - Schizophrenia

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=0032851146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032851146&partnerID=8YFLogxK

U2 - 10.1016/S0306-4522(99)00279-1

DO - 10.1016/S0306-4522(99)00279-1

M3 - Article

C2 - 10613493

AN - SCOPUS:0032851146

VL - 94

SP - 21

EP - 31

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 1

ER -